Lung functional decline in patients with Interstitial Pneumonia with Autoimmune Features (IPAF)
A. Nagy (Mosonmagyaróvár, Hungary), E. Palmer (Budapest, Hungary), E. Bárczi (Budapest, Hungary), A. Farkas (Budapest, Hungary), T. Erdélyi (Budapest, Hungary), K. Vincze (Budapest, Hungary), N. Eszes (Budapest, Hungary), A. Bohács (Budapest, Hungary), V. Müller (Budapest, Hungary)
Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Nagy (Mosonmagyaróvár, Hungary), E. Palmer (Budapest, Hungary), E. Bárczi (Budapest, Hungary), A. Farkas (Budapest, Hungary), T. Erdélyi (Budapest, Hungary), K. Vincze (Budapest, Hungary), N. Eszes (Budapest, Hungary), A. Bohács (Budapest, Hungary), V. Müller (Budapest, Hungary). Lung functional decline in patients with Interstitial Pneumonia with Autoimmune Features (IPAF). 2376
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: